Pediatric Endocrinology & Diabetes Research
Investigators in NYU Langone’s Division of Pediatric Endocrinology and Diabetes have diverse areas of interest and engage in a wide range of research activities. Their work is published in numerous peer-reviewed journals, and division members frequently deliver lectures at scientific conferences and other academic medical centers.
Research in the division focuses on pediatric diabetes and pediatric disorders that affect growth, the adrenal glands, and the pituitary gland. Investigators study the effects of medications and vitamins on the pediatric endocrine system, including hypercalcemia and problems with growth. Researchers have also studied the adverse effects of growth hormone therapies for puberty induction.
The investigators have studied geographic disparities in diabetes prevalence, as well as cortisol levels in children with diabetic ketoacidosis at diagnosis of new-onset type 1 diabetes mellitus. The division has been involved in the development of guidelines for children and adolescents with thyroid cancer.
Recent Publications
Increasing Social Determinants of Health Screening Rates Among Six Endocrinology Centers Across the United States: Results From the T1D Exchange Quality Improvement Collaborative
Clinical diabetes. 2024 Dec 01; 42:49-55
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
Diabetologia. 2024 Sep 04;
Type 1 and Covid-19: Diagnosis, Clinical Care, and Health Outcomes during the Pandemic
Endocrinology & metabolism clinics of North America. 2024 Mar ; 53:135-149
The Design of the Electronic Health Record in Type 1 Diabetes Centers: Implications for Metrics and Data Availability for a Quality Collaborative
Journal of diabetes science & technology. 2023 Nov 23; 19322968231214539
Lipoprotein(a): a Case for Universal Screening in Youth
Current atherosclerosis reports. 2023 Aug ; 25:487-493
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data™
BMJ open. 2023 Jul 09; 13:e071475
Can Surrogate Markers Help Define Cardiovascular Disease in Youth?
Current atherosclerosis reports. 2023 Jun ; 25:275-298
Update on management of paediatric dyslipidaemia
Current opinion in endocrinology, diabetes, & obesity. 2023 Feb 01; 30:52-64